Finlay McFadyen, head of investment banking, AIB Group; Fountain Healthcare partner Dr Manus Rogan; and Andrew McDowell, vice-president, European Investment Bank. Photograph: Nick Bradshaw

Irish life sciences venture capital group Fountain Healthcare Partners has raised €118 million in a new fund. The sum is well in excess of the €100 m(...)

The 2018 deal values were skewered by the €54 billion approach by Japan’s Takeda Pharmaceutical for Dublin-headquartered Shire

There was a jump in mergers and acquisitions in the State last year. The value of such deals surged, new figures from Mergermarket show. The value of(...)

PwC has reportedly been appointed to review spiralling costs at the new Children’s hospital

Minister for Finance Paschal Donohoe met senior executives from Apple while on a trade mission to Silicon Valley last week, according to the Sunday Bu(...)

 Inflazome chief executive Prof Matt Cooper  with  co-founder Prof Luke O’Neill (centre) with  Fountain Healthcare Partners managing director Dr Manus Rogan (left) and and  Dr Jeremy Skillington, vice-president of business development at Inflazome. Photograph: Nick Bradshaw

An Irish start-up drug development company that is targeting a series of inflammatory conditions has raised €40 million to fund clinical trials. The (...)

John Thero: “We’re taking the approach of make it [Vascepa] affordable, and hopefully we can help millions of patients and make some money along the way”

Stunning they called it. And it was, as Irish-American pharma group Amarin announced the results of a key clinical trial for its cholesterol drug last(...)

Kandy Therapeutics is  set to advance trials on a drug it believes could help women deal with hot flushes and night-time sweats linked to menopause. Photograph: PA Wire

Women’s healthcare group Kandy Therapeutics has raised £25 million (€27.50 million) to advance trials on a product it believes could help millions of (...)

The ReActiv8 unit is designed to treat disabling pain in patients with chronic lower back pain through the use of an implant that stimulates nerves to strengthen muscles in the lower back

Back pain group Mainstay Medical has successfully implanted 204 patients with its Reactiv8 device as part of a clinical trial to access the key United(...)

Neurent Medical founders David Townley, chief technology officer and Brian Shields, chief executive: The company hopes to begin the first of two clinical trials next year, possibly in the US. Photograph: Michael Dillon

An Irish company developing a breakthrough therapy for a common nasal condition has raised €9.3 million. Neurent Medical, based in Oranmore, Co Galwa(...)

Dr Michael O’Neill, director of research and development at Inflection Biosciences, Darren Cunningham, chief executive at Inflection and Prof Bryan Hennessy, senior clinical lecturer at RCSI and consultant medical oncologist. Photograph: Julien Behal

Irish drug development company Inflection Biosciences will present data on its fledgling breakthrough breast cancer therapy to the American Associatio(...)

The Syndesi Therapeutics drug is directly targeting dementia, the core symptom of Alzheimer’s disease. Photograph:  John Stillwell/PA

Irish venture capital group Fountain Healthcare has invested in a Belgian start-up that is investigating a dementia therapy. The company, Syndesi The(...)

  • 1
  • 2
  • 3
  • 4
  • Next
  • Last »